Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents
- PMID: 17609322
- PMCID: PMC2045270
- DOI: 10.1128/JCM.00551-07
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents
Abstract
As part of a United States-based multicenter clinical trial, conducted from 2001 to 2004, that compared ertapenem to piperacillin-tazobactam for the treatment of moderate-to-severe diabetic foot infections (DFIs), we obtained 454 pretreatment specimens from 433 patients. After debridement, the investigators collected wound specimens, mostly by curettage or biopsy, and sent them to the R. M. Alden Research Laboratory for aerobic and anaerobic culture. Among the 427 positive cultures, 83.8% were polymicrobial, 48% grew only aerobes, 43.7% had both aerobes and anaerobes, and 1.3% had only anaerobes. Cultures yielded a total of 1,145 aerobic strains and 462 anaerobic strains, with an average of 2.7 organisms per culture (range, 1 to 8) for aerobes and 2.3 organisms per culture (range, 1 to 9) for anaerobes. The predominant aerobic organisms were oxacillin-susceptible Staphylococcus aureus (14.3%), oxacillin-resistant Staphylococcus aureus (4.4%), coagulase-negative Staphylococcus species (15.3%), Streptococcus species (15.5%), Enterococcus species (13.5%), Corynebacterium species (10.1%), members of the family Enterobacteriaceae (12.8%), and Pseudomonas aeruginosa (3.5%). The predominant anaerobes were gram-positive cocci (45.2%), Prevotella species (13.6%), Porphyromonas species (11.3%), and the Bacteroides fragilis group (10.2%). Pure cultures were noted for 20% of oxacillin-resistant Staphylococcus aureus cultures, 9.2% of Staphylococcus epidermidis cultures, and 2.5% of P. aeruginosa cultures. Two or more species of Staphylococcus were present in 13.1% of the patients. Ertapenem and piperacillin-tazobactam were each active against >98% of the enteric gram-negative rods, methicillin-sensitive S. aureus, and anaerobes. Among the fluoroquinolones, 24% of anaerobes, especially the gram-positive cocci, were resistant to moxifloxacin; 27% of the gram-positive aerobes but only 6% of the members of the family Enterobacteriaceae were resistant to levofloxacin. Moderate-to-severe DFIs are typically polymicrobial, and almost half include anaerobes. Our antibiotic susceptibility results can help to inform therapeutic choices.
Similar articles
-
Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.Diagn Microbiol Infect Dis. 2013 Jul;76(3):347-51. doi: 10.1016/j.diagmicrobio.2013.03.019. Epub 2013 Apr 24. Diagn Microbiol Infect Dis. 2013. PMID: 23623385
-
Study of fungal and bacterial infections of the diabetic foot.Indian J Pathol Microbiol. 2002 Jan;45(1):15-22. Indian J Pathol Microbiol. 2002. PMID: 12593559
-
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.J Antimicrob Chemother. 2005 Nov;56(5):872-8. doi: 10.1093/jac/dki348. Epub 2005 Sep 26. J Antimicrob Chemother. 2005. PMID: 16186167
-
A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.Diagn Microbiol Infect Dis. 1997 Aug;28(4):157-63. doi: 10.1016/s0732-8893(97)00065-5. Diagn Microbiol Infect Dis. 1997. PMID: 9327242 Review.
-
In vitro activity of ertapenem: review of recent studies.J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii11-21. doi: 10.1093/jac/dkh204. J Antimicrob Chemother. 2004. PMID: 15150179 Review.
Cited by
-
Agarose bioplastic-based drug delivery system for surgical and wound dressings.Eng Life Sci. 2016 Oct 12;17(2):204-214. doi: 10.1002/elsc.201500116. eCollection 2017 Feb. Eng Life Sci. 2016. PMID: 32624768 Free PMC article.
-
Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competition.PLoS Pathog. 2022 Sep 6;18(9):e1010766. doi: 10.1371/journal.ppat.1010766. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36067266 Free PMC article.
-
Biofilm Survival Strategies in Chronic Wounds.Microorganisms. 2022 Apr 5;10(4):775. doi: 10.3390/microorganisms10040775. Microorganisms. 2022. PMID: 35456825 Free PMC article. Review.
-
Prolonged use of ertapenem to treat infected diabetic foot ulcers.Case Rep Med. 2010;2010:149591. doi: 10.1155/2010/149591. Epub 2010 Sep 28. Case Rep Med. 2010. PMID: 20936155 Free PMC article.
-
In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.Antimicrob Agents Chemother. 2010 Apr;54(4):1627-32. doi: 10.1128/AAC.01788-09. Epub 2010 Jan 25. Antimicrob Agents Chemother. 2010. PMID: 20100877 Free PMC article.
References
-
- Abdulrazak, A., Z. I. Bitar, A. A. Al-Shamali, and L. A. Mobasher. 2005. Bacteriological study of diabetic foot infections. J. Diabetes Complications 19:138-141. - PubMed
-
- Armstrong, D. G., P. J. Liswood, and W. F. Todd. 1995. 1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J. Am. Podiatr. Med. Assoc. 85:533-537. - PubMed
-
- Asfar, S. K., M. al-Arouj, A. al-Nakhi, A. Baraka, T. Juma, and M. Johny. 1993. Foot infections in diabetics: the antibiotic choice. Can. J. Surg. 36:170-172. - PubMed
-
- Bessman, A. N., P. J. Geiger, and H. Canawati. 1992. Prevalence of Corynebacteria in diabetic foot infections. Diabetes Care 15:1531-1533. - PubMed
-
- Bowler, P. G., and B. J. Davies. 1999. The microbiology of infected and noninfected leg ulcers. Int. J. Dermatol. 38:573-578. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials